|
|
|||||||||||
EDITORIALS |
University Department of Psychiatry, Warneford Hospital, Oxford, UK
Correspondence: Dr Sepehr Hafizi, Neurosciences Building, University Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, UK. Email: sepehr.hafizi{at}psych.ox.ac.uk
Declaration of interest P.J.C. has received payment for serving as a member of advisory boards of several pharmaceutical companies. Funding detailed in Acknowledgements.
Based upon animal experiments and early clinical trials, neurokinin-1 receptor antagonists showed promise as novel antidepressants. Subsequently, however, more extensive clinical trials did not reveal evidence of efficacy in depression. The development of novel antidepressants will require a better understanding of the neural basis of antidepressant action in humans.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |